Judith S Currier

Judith S Currier

UNVERIFIED PROFILE

Are you Judith S Currier?   Register this Author

Register author
Judith S Currier

Judith S Currier

Publications by authors named "Judith S Currier"

Are you Judith S Currier?   Register this Author

100Publications

2265Reads

23Profile Views

Monthly Injectable Antiretroviral Therapy - Version 1.0 of a New Treatment Approach.

Authors:
Judith S Currier

N Engl J Med 2020 03 4;382(12):1164-1165. Epub 2020 Mar 4.

From the UCLA Medical Center, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe2002199DOI Listing
March 2020

The Role of Inflammation in HIV-Associated Atherosclerosis-One Size May Not Fit All.

J Infect Dis 2020 Feb;221(4):495-497

University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiz256DOI Listing
February 2020

Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.

Prog Cardiovasc Dis 2020 Feb 18. Epub 2020 Feb 18.

Division of General Internal Medicine and Health Services Research, Department of Medicine, UCLA Geffen School of Medicine, Los Angeles, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pcad.2020.02.012DOI Listing
February 2020

Antiretroviral therapy initiation is associated with decreased visceral and subcutaneous adipose tissue density in people living with HIV.

Clin Infect Dis 2020 Feb 28. Epub 2020 Feb 28.

University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciaa196DOI Listing
February 2020

Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077.

Clin Infect Dis 2020 Jan;70(2):319-322

Division of Infectious Diseases, Department of Medicine, Center for AIDS Research and Education & Center for HIV Prevention, David Geffen School of Medicine at University of California, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938971PMC
January 2020

Immune Biomarkers in the Prediction of Future Myocardial Infarction in People with HIV.

Clin Infect Dis 2019 Aug 15. Epub 2019 Aug 15.

Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz765DOI Listing
August 2019

CROI 2019: complications and coinfections in HIV infection.

Top Antivir Med 2019 Apr;27(1):34-40

University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550358PMC
April 2019

Outcomes of a Career Development Program for Underrepresented Minority Investigators in the AIDS Clinical Trials Group.

Open Forum Infect Dis 2019 Mar 11;6(3):ofz069. Epub 2019 Feb 11.

Division of Infectious Diseases, Department of Medicine, University of Colorado-Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofz069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419986PMC
March 2019

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy.

Open Forum Infect Dis 2019 Feb 12;6(2):ofz022. Epub 2019 Feb 12.

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofz022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372057PMC
February 2019

Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy.

PLoS One 2018 18;13(7):e0199555. Epub 2018 Jul 18.

Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199555PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051581PMC
December 2018

Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate.

Arterioscler Thromb Vasc Biol 2018 12;38(12):2870-2878

From the Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison (J.H.S., J.M.W., C.K., C.K.C.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.118.311807DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309804PMC
December 2018

CROI 2018: Complications of HIV Infection and Antiretroviral Therapy.

Top Antivir Med 2018 May;26(1):22-29

University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963934PMC
May 2018

Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease.

Authors:
Judith S Currier

Top Antivir Med 2018 Apr;25(4):133-137

University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935217PMC
April 2018

Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.

N Engl J Med 2018 04;378(17):1593-1603

From the Departments of Epidemiology (K.R., G.R.S., P.L.W., S.H.-D., K.P.) and Biostatistics (P.L.W., D.E.S.) and the Center for Biostatistics and AIDS Research (Y.H., D.E.S., K.P.), Harvard T.H. Chan School of Public Health, and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (K.R.), Boston; the Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago (E.G.C.); the Department of Medicine and Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (J.S.C., R.M.H.); and the Department of Pediatrics, University of Colorado School of Medicine, Aurora (E.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701666DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984044PMC
April 2018

Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry.

Rapid Commun Mass Spectrom 2018 Mar;32(5):431-441

Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rcm.8058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848502PMC
March 2018

CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment.

Top Antivir Med 2017 May/Jun;25(2):77-83

University of Caliofrnia San Francisco and San Francisco General Hospital, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677045PMC
February 2018

Transgender Women Living with HIV Frequently Take Antiretroviral Therapy and/or Feminizing Hormone Therapy Differently Than Prescribed Due to Drug-Drug Interaction Concerns.

LGBT Health 2017 10 6;4(5):371-375. Epub 2017 Sep 6.

2 South American Program in HIV Prevention Research, Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine , Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/lgbt.2017.0057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661861PMC
October 2017

Antiretroviral initiation is associated with increased skeletal muscle area and fat content.

AIDS 2017 08;31(13):1831-1838

aUniversity of Colorado Anschutz Medical Campus, Aurora, Colorado bCase Western University, Cleveland, Ohio cUniversity of Texas Health Sciences Center, Houston, Texas dUniversity of Wisconsin School of Medicine and Public Health, Madison, Wisconsin eUniversity of California, Los Angeles, California fJohns Hopkins University, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533189PMC
August 2017

Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals.

J Acquir Immune Defic Syndr 2017 07;75(3):354-363

*Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA; †Children's Hospital Oakland Research Institute, Oakland, CA; and ‡Department of Medicine Statistics Core, UCLA, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472482PMC
July 2017

CROI 2016: Complications of HIV Infection and Antiretroviral Therapy.

Top Antivir Med 2016 May-Jun;24(1):38-46

Clinical AIDS Research and Education (CARE) Center at University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148923PMC
April 2017

Factors associated with retention in Option B+ in Malawi: a case control study.

J Int AIDS Soc 2017 Apr;20(1):21464

Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7448/IAS.20.01.21464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515033PMC
April 2017

Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.

HIV Clin Trials 2016 11 23;17(6):225-232. Epub 2016 Sep 23.

a Division of Infectious Diseases, Department of Medicine , University of California , Los Angeles , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15284336.2016.1234222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470589PMC
November 2016

Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.

AIDS 2016 11;30(17):2625-2633

aDavid Geffen School of Medicine at University of California - Los Angeles bUCLA Department of Medicine Statistics Core, Los Angeles, California cCase Western Reserve University, Cleveland, Ohio dKeck School of Medicine at the University of Southern California, Los Angeles, California eJohns Hopkins University, Baltimore, Maryland fUniversity of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083154PMC
http://dx.doi.org/10.1097/QAD.0000000000001238DOI Listing
November 2016

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

N Engl J Med 2016 11;375(18):1726-1737

From the Department of Pathology, Johns Hopkins University School of Medicine (M.G.F.), and the Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health (T.E.T.), Baltimore, and the Division of AIDS, National Institute of Allergy and Infectious Diseases (D.G., K.L.K., R. Browning, L.P.), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (G.K.S.), National Institutes of Health, Bethesda - all in Maryland; the Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston (M.Q., T.F., D.E.S.); the Retrovirology Core Laboratory, University of North Carolina School of Medicine, Chapel Hill (S.A.F., A.J.L.), and FHI 360, Durham (A.S.C.) - both in North Carolina; the UCLA Center for Clinical AIDS Research and Education, Los Angeles (J.S.C.); St. Jude Children's Research Hospital, Memphis, TN (P.M.F.); the Department of Obstetrics and Gynecology, College of Health Sciences, University of Zimbabwe, Harare (T.C.); Anova Health Institute (J.M.), Perinatal HIV Research Unit, University of the Witwatersrand, Faculty of Health Sciences (A.V.), and Empilweni Services and Research Unit (R.S.), Johannesburg, School of Public Health and Family Medicine, University of Cape Town (J.M.), and the Department of Obstetrics and Gynaecology, Stellenbosch University (G.B.T.), Cape Town, and the Centre for the AIDS Programme of Research in South Africa-Umlazi Clinical Research Site (D.M.) and Durban Paediatric HIV (R. Bobat), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban - all in South Africa; the University of North Carolina Project, Kamuzu Central Hospital-Tidziwe Center, Lilongwe, Malawi (F.E.M.); Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda (M.O.); the Department of Obstetrics and Gynecology, B.J. Medical College, Pune, India (R. Bhosale); the Centre for Infectious Disease Research in Zambia, Lusaka, Zambia (B.H.C.); Kilimanjaro Christian Medical Center-Duke University Collaboration, Moshi, Tanzania (P.M.); Frontier Science and Technology Research Foundation, Amherst, NY (M.B.); and the Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC (L.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1511691DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214343PMC
November 2016

Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation.

J Acquir Immune Defic Syndr 2016 10;73(2):123-9

*Division of Infectious Diseases, Center for Global Health, Weill Cornell Medical College, New York, NY; †Johns Hopkins Clinical Trials Unit, Byramjee Jeejeebhoy Government Medical College, Pune, India; ‡Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD; §Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA; ‖Department of Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe; ¶Division of Infectious Diseases, Hospital Nossa Senhora de Conceição, Porto Alegre, Brazil; #Les Centres GHESKIO, Port-Au-Prince, Haiti; **Department of Medicine, University of North Carolina-Lilongwe, Lilongwe, Malawi; ††Research Institute for Health Sciences, Chiang Mai, Thailand; ‡‡Impacta Peru, San Miguel, Peru; §§Durban International Clinical Research Site, Durban University of Technology, Durban, South Africa; ‖‖STD/AIDS Clinical Research Laboratory, Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil; ¶¶Department of Medicine, University of Witwatersrand, Johannesburg, South Africa; ##National AIDS Research Institute (ICMR), Pune, India; ***Malawi College of Medicine-Johns Hopkins University Research Project, Blantyre, Malawi; †††YRGCARE Medical Center, Chennai, India; ‡‡‡Investigative Medicine Branch, Laboratório Integrado de Microbiologia e Imunorregulação (LIMI), Centro de Pesquisas Gonçalo Moniz (CPqGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil; §§§Division of Infectious Diseases, University of Colorado-Denver, Aurora, CO; ‖‖‖Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; and ¶¶¶Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023467PMC
October 2016

Making waves: safety and efficacy of ART in women.

Lancet HIV 2016 09 27;3(9):e398-e399. Epub 2016 May 27.

Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(16)30033-9DOI Listing
September 2016

Reimann's "Habitual Hyperthermia" Responding to Hormone Therapy.

Open Forum Infect Dis 2016 Sep 26;3(3):ofw127. Epub 2016 Jul 26.

Division of Infectious Diseases, Department of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofw127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084720PMC
September 2016

CROI 2015: Complications of HIV Infection and Antiretroviral Therapy.

Top Antivir Med 2015 Mar-Apr;23(1):56-65

University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148904PMC
April 2016

Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.

AIDS Res Hum Retroviruses 2016 Mar 16;32(3):247-54. Epub 2015 Nov 16.

1 Department of Medicine, Division of Infectious Diseases, and Center for Clinical AIDS Research and Education (CARE), David Geffen School of Medicine, University of California , Los Angeles, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2015.0200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779972PMC
March 2016

Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners.

J Infect Dis 2015 Nov 19;212(10):1534-43. Epub 2015 Jun 19.

Department of Medicine, Division of Infectious Diseases, University of California, David Geffen School of Medicine, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiv305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621256PMC
November 2015

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.

AIDS 2015 Oct;29(16):2121-9

aDivision of Infectious Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania bCenter for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts cDivison of Infectious Diseases, Department of Medicine, Henry Ford Hospital, Detroit, Michigan dDepartment of Laboratory Medicine and Medicine, School of Medicine, University of Washington, Seattle, Washington eDepartment of Medicine, Rush University Medical Center, Chicago, Illinois fHIV Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland gDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts hDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, California iDivision of Infectious Diseases, Weill Medical College, Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000810DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638139PMC
October 2015

A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.

AIDS 2015 Sep;29(14):1775-83

aUniversity of Wisconsin School of Medicine and Public Health, Madison, Wisconsin bHarvard School of Public Health, Boston, Massachusetts cKeck School of Medicine, University of Southern California, Los Angeles, California dJohns Hopkins University School of Medicine, Baltimore, Maryland eCase School of Medicine, Cleveland, Ohio fFeinberg School of Medicine, Northwestern University, Chicago, Illinois gDavid Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000762DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571277PMC
September 2015

A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL.

PLoS One 2014 4;9(11):e111716. Epub 2014 Nov 4.

Department of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111716PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219769PMC
June 2015

Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.

AIDS 2015 Jun;29(10):1173-82

aJohns Hopkins University, Baltimore, Maryland bHarvard School of Public Health, Boston, Massachusetts, USA cYRG Centre for AIDS Research and Education, Voluntary Health Services Hospital Campus, Taramani, Chennai dNational AIDS Research Institute-ICMR, Pune, India eUniversity of Zimbabwe Clinical Research Centre, College of Health Sciences, Harare, Zimbabwe fCollege of Medicine, Johns Hopkins Research Project, Department of Medicine, Blantyre, Malawi gNelson R Mandela School of Medicine, University of KwaZulu-Natal, Glenwood, South Africa hUniversity of Colorado School of Medicine, Aurora, Colorado iBrigham and Women's Hospital, Boston, Massachusetts jUCLA David Geffen School of Medicine, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000686DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535336PMC
June 2015

Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.

AIDS Rev 2014 Jul-Sep;16(3):123-33

Department of Medicine, Division of Endocrinology and Metabolism, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067015PMC
March 2015

Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity.

PLoS One 2014 21;9(3):e89928. Epub 2014 Mar 21.

Harvard AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America; Botswana-Harvard AIDS Institute, Gaborone, Botswana; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0089928PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962339PMC
January 2015

The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.

Open Forum Infect Dis 2014 Dec 3;1(3):ofu104. Epub 2014 Dec 3.

Department of Medicine , David Geffen School of Medicine at University of California, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofu104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324212PMC
December 2014

Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences.

J AIDS Clin Res 2014 Nov;5(11)

UCLA Division of Infectious Diseases and Center for Clinical AIDS Research and Education, Department of Medicine, David Geffen School of Medicine at UCLA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4172/2155-6113.1000366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409003PMC
November 2014

Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals.

J Acquir Immune Defic Syndr 2014 Sep;67(1):30-5

*Department of Medicine, MetroHealth Medical Center; Cleveland, OH; †Geriatric Research Education and Clinical Centers, Louis Stokes Cleveland Veterans Administration, Cleveland, OH; ‡Statistical and Data Analysis Center, Harvard School of Public Health; Boston, MA; §Department of Neurology and Neurological Surgery, Washington University of St. Louis, St. Louis, MO; ‖UCLA CARE Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; and ¶Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133749PMC
September 2014

Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.

Endocrinol Metab Clin North Am 2014 Sep;43(3):665-84

Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, UCLA, 9911 W. Pico Boulevard, Suite 980, Los Angeles, CA 90035, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054418PMC
http://dx.doi.org/10.1016/j.ecl.2014.06.003DOI Listing
September 2014

Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?

JACC Cardiovasc Imaging 2014 May;7(5):515-25

Division of Cardiology, University of California-San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcmg.2013.08.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024182PMC
May 2014

CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy.

Top Antivir Med 2014 May;22(2):602-15

University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148912PMC
May 2014

CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy.

Top Antivir Med 2013 Apr-May;21(2):62-74

University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148869PMC
December 2013

Metabolic disease in HIV infection.

Lancet Infect Dis 2013 Nov;13(11):964-75

David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(13)70271-8DOI Listing
November 2013

A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial.

PLoS One 2013 14;8(3):e58135. Epub 2013 Mar 14.

Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058135PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597631PMC
September 2013

Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery.

J Acquir Immune Defic Syndr 2013 Aug;63(5):593-601

*Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; †Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA; and ‡National Vaccine Program Office/Office of the Assistant Secretary for Health/Office of the Secretary/Department of Health and Human Services, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31829b0b9fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868443PMC
August 2013

Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.

AIDS Res Hum Retroviruses 2013 Jun 25;29(6):938-48. Epub 2013 Feb 25.

Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA 90035, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2012.0305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653400PMC
June 2013

Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults.

Lipids Health Dis 2013 Mar 5;12:23. Epub 2013 Mar 5.

Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-511X-12-23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602051PMC
March 2013